Skip to main content
Supplement ScienceSupplementScience

Types of L-Carnitine: Forms & Bioavailability

Evidence:Moderate
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Forms Comparison

FormBioavailabilityBest For
L-Carnitine L-Tartrate (LCLT)Moderate (~15-18% oral)Exercise recovery — most researched form for athletic performance and muscle damage reduction
Acetyl-L-Carnitine (ALCAR)Moderate (crosses blood-brain barrier)Brain health — the acetyl group allows it to cross the blood-brain barrier; best for cognitive support
L-Carnitine (base form)Low-Moderate (~14-18%)General use — cheapest form; adequate for general carnitine supplementation
Propionyl-L-Carnitine (GPLC)ModerateCardiovascular / peripheral circulation — some evidence for intermittent claudication and blood flow

L-Carnitine L-Tartrate (LCLT)

Bioavailability: Moderate (~15-18% oral). Best for: Exercise recovery — most researched form for athletic performance and muscle damage reduction.

Acetyl-L-Carnitine (ALCAR)

Bioavailability: Moderate (crosses blood-brain barrier). Best for: Brain health — the acetyl group allows it to cross the blood-brain barrier; best for cognitive support.

L-Carnitine (base form)

Bioavailability: Low-Moderate (~14-18%). Best for: General use — cheapest form; adequate for general carnitine supplementation.

Propionyl-L-Carnitine (GPLC)

Bioavailability: Moderate. Best for: Cardiovascular / peripheral circulation — some evidence for intermittent claudication and blood flow.

Full L-Carnitine Guide

References

  1. RCTSpiering BA, Kraemer WJ, Vingren JL, et al. (2007). Responses of criterion variables to different supplemental doses of L-carnitine L-tartrate. Journal of Strength and Conditioning Research. DOI PubMed
  2. RCTWall BT, Stephens FB, Constantin-Teodosiu D, et al. (2011). Chronic oral ingestion of L-carnitine and carbohydrate increases muscle carnitine content and alters muscle fuel metabolism during exercise in humans. Journal of Physiology. DOI PubMed
  3. Meta-analysisMontgomery SA, Thal LJ, Amrein R (2003). Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. International Clinical Psychopharmacology. DOI PubMed
  4. Ma X, Yang Y, Liu S, Cui Y, et al. (2025). Meta-analysis of the efficacy and safety of L-carnitine and N-acetylcysteine monotherapy for male idiopathic infertility.. Revista internacional de andrologia. DOI PubMed
  5. Hamedi-Kalajahi F, Zarezadeh M, Malekahmadi M, Jamilian P, et al. (2025). The Effect of the L-Carnitine Supplementation on Obesity Indices: An Umbrella Meta-Analysis.. International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition. DOI PubMed
  6. Meta-analysisMirrafiei A, Jayedi A, Shab-Bidar S (2024). The Effects of L-Carnitine Supplementation on Weight Loss, Glycemic Control, and Cardiovascular Risk Factors in Patients With Type 2 Diabetes: A Systematic Review and Dose-response Meta-Analysis of Randomized Controlled Trials.. Clinical therapeutics. DOI PubMed
  7. Li Y, Xie Y, Qiu C, Yu B, et al. (2023). Effects of L-carnitine supplementation on glucolipid metabolism: a systematic review and meta-analysis.. Food & function. DOI PubMed
Show 5 more references
  1. Meta-analysisRastgoo S, Fateh ST, Nikbaf-Shandiz M, Rasaei N, et al. (2023). The effects of L-carnitine supplementation on inflammatory and anti-inflammatory markers in adults: a systematic review and dose-response meta-analysis.. Inflammopharmacology. DOI PubMed
  2. Guedes GV, Minicucci MF, Tanni SE (2022). The supplementation of L-carnitine in septic shock patients: Systematic review and meta-analysis.. Clinics (Sao Paulo, Brazil). DOI PubMed
  3. Mohd Shukri MF, Norhayati MN, Badrin S, Abdul Kadir A (2022). Effects of L-carnitine supplementation for women with polycystic ovary syndrome: a systematic review and meta-analysis.. PeerJ. DOI PubMed
  4. Wei G, Zhou Z, Cui Y, Huang Y, et al. (2021). A Meta-Analysis of the Efficacy of L-Carnitine/L-Acetyl-Carnitine or N-Acetyl-Cysteine in Men With Idiopathic Asthenozoospermia.. American journal of men's health. DOI PubMed
  5. Weng Y, Zhang S, Huang W, Xie X, et al. (2021). Efficacy of L-Carnitine for Dilated Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.. BioMed research international. DOI PubMed